We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App

New Fluorescent Sensor Array Lights up Alzheimer’s-Related Proteins for Earlier Detection

By LabMedica International staff writers
Posted on 08 Feb 2024
Print article
Image: Lighting up Alzheimer’s-related proteins allows for earlier disease detection (Photo courtesy of 123RF)
Image: Lighting up Alzheimer’s-related proteins allows for earlier disease detection (Photo courtesy of 123RF)

Many neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, pose a diagnostic challenge in their early stages before symptoms manifest. Identifying disease-related biomarkers like amyloids, which are aggregated proteins, could offer crucial early insights if they can be detected effectively. Now, researchers have developed a new method that employs an array of sensor molecules to illuminate amyloids. This innovation could play a significant role in monitoring disease progression or differentiating various amyloid-related disorders.

In neurodegenerative diseases, a common factor is the disruption of brain communication, often due to “sticky” clumps of misfolded proteins called amyloids that interrupt signal transmission. These amyloids are believed to be integral to Alzheimer’s disease progression, suggesting their potential as early diagnostic markers to broaden treatment possibilities. While radioimaging techniques like positron emission tomography (PET) scans can detect amyloids, they require advanced equipment and generally target only specific amyloids linked to the disease. As an alternative, fluorescence imaging techniques have been investigated for their simpler yet sensitive capability to detect multiple distinct amyloids.

A team of researchers at The University of Sydney (NSW, Australia) set out to develop a fluorescent sensor array specifically for amyloids. This tool aims to monitor Alzheimer’s and other diseases' progression and differentiate atypical amyloids from other naturally occurring amyloid-forming proteins. The team initially combined five coumarin-based molecular probes, each responding with varying fluorescence levels upon encountering amyloids, into an array. They discovered, however, that using just two of these probes, chosen for their strong fluorescence responses, still yielded a highly sensitive detection system and provided a unique fluorescent “fingerprint” for individual amyloids.

The effectiveness of this two-probe array was tested in a simulated biological fluid containing molecules that could potentially disrupt sensing. Nevertheless, the array maintained its high sensitivity and selectivity. Its efficacy was further validated using samples from the brains of mouse models of Alzheimer’s. The researchers noted distinct fluorescence patterns at the early (6 months old) and later (12 months old) stages of the disease. Moreover, the array produced a distinct fluorescence signature for three amyloids typically associated with Alzheimer’s, another disease-related amyloid, and five “functional amyloids” not implicated in the disease. According to the researchers, this tool offers the potential to differentiate between closely related amyloids, paving the way for earlier and more precise diagnosis of amyloid-related diseases.

Related Links:
The University of Sydney

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article


Molecular Diagnostics

view channel
Image: Prostate cancer cell image taken using a scanning electron microscope (Photo courtesy of LRI EM Unit)

New Discoveries of Prostate Cancer Evolution Pave Way for Genetic Test

Prostate cancer ranks as one of the most common cancers affecting men, and while it accounts for a significant number of male cancer fatalities, many men live with it rather than die from it.... Read more


view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more


view channel
Image: The photoacoustic spectral response sensing instrument is based on low-cost laser diodes (Photo courtesy of Khan et al., doi 10.1117/1.JBO.29.1.017002)

Compact Photoacoustic Sensing Instrument Enhances Biomedical Tissue Diagnosis

The pursuit of precise and efficient diagnostic methods is a top priority in the constantly evolving field of biomedical sciences. A promising development in this area is the photoacoustic (PA) technique.... Read more


view channel
Image: The companies will develop genetic testing systems based on capillary electrophoresis sequencers (Photo courtesy of 123RF)

Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems

Sysmex Corporation (Kobe, Japan) and Hitachi High-Tech Corporation (Tokyo, Japan) have entered into a collaboration for the development of genetic testing systems using capillary electrophoresis sequencers... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.